108 related articles for article (PubMed ID: 884683)
1. Detection of soluble tumor-associated antigens in serum of tumor-bearing rats and their immunological role in vivo.
Srinivasa Rao V; Bonavida B
Cancer Res; 1977 Sep; 37(9):3385-9. PubMed ID: 884683
[TBL] [Abstract][Full Text] [Related]
2. Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens.
Rao VS; Bonavida B
Cancer Res; 1976 Apr; 36(4):1384-91. PubMed ID: 56998
[TBL] [Abstract][Full Text] [Related]
3. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
Bernstein ID
J Immunol; 1977 Jan; 118(1):122-8. PubMed ID: 830744
[TBL] [Abstract][Full Text] [Related]
4. In vivo protection against syngeneic Gross virus-induced lymphoma in rats: comparison with in vitro studies of cell-mediated immunity.
Glaser M; Lavrin DH; Herberman RB
J Immunol; 1976 Jun; 116(6):1507-11. PubMed ID: 58036
[TBL] [Abstract][Full Text] [Related]
5. Presence of complement-fixing antibodies against antigens of Gross virus-induced rat lymphoma and normal rat thymus in sera of patients with some forms of malignancies.
Simkovic D; Chorváth B; Hlubinová K; Valentová N; Stevonková J; Babusíková O; Simkovicová M
Neoplasma; 1977; 24(4):357-63. PubMed ID: 269322
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of cell-mediated cytotoxicity against syngeneic Gross virus-induced lymphoma in rats by phytohemagglutinin and endotoxin.
Glaser M; Djeu JY; Kirchner H; Herberman RB
J Immunol; 1976 Jun; 116(6):1512-9. PubMed ID: 774985
[TBL] [Abstract][Full Text] [Related]
7. In vitro generation of secondary cell-mediated cytotoxic response against a syngeneic Gross virus-induced lymphoma in rats.
Glaser M; Bonnard GD; Herberman RB
J Immunol; 1976 Feb; 116(2):430-6. PubMed ID: 1082456
[TBL] [Abstract][Full Text] [Related]
8. Generation of cytotoxic lymphocytes in vitro: response of immune rat spleen cells to a syngeneic gross virus-induced lymphoma in mixed lymphocyte-tumor culture.
Bernstein ID; Wright PW; Cohen E
J Immunol; 1976 May; 116(5):1367-72. PubMed ID: 58029
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts.
Shimizu J; Zou JP; Ikegame K; Katagiri T; Fujiwara H; Hamaoka T
J Immunol; 1991 Mar; 146(5):1708-14. PubMed ID: 1993850
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
Fuyama S; Yamamoto H; Fujii Y; Arai S
Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
[TBL] [Abstract][Full Text] [Related]
11. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
Weinhold KJ; Wheelock EF
Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
[TBL] [Abstract][Full Text] [Related]
12. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
Vallera DA; Mentzer SJ; Maizel SE
Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
[TBL] [Abstract][Full Text] [Related]
13. In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus.
Iglehart JD; Weinhold KJ; Huper G; Thiel K; Bolognesi DP
J Natl Cancer Inst; 1981 Jul; 67(1):123-30. PubMed ID: 6265678
[TBL] [Abstract][Full Text] [Related]
14. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
Sensi ML; Parenza M; Parmiani G
J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
[TBL] [Abstract][Full Text] [Related]
15. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
16. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
17. T cells from naive mice suppress the in vitro cytotoxic response against endogenous Gross virus-induced tumor cells.
Tilkin AF; Gomard E; Begue B; Levy JP
J Immunol; 1984 Jan; 132(1):520-6. PubMed ID: 6228582
[TBL] [Abstract][Full Text] [Related]
18. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity.
Kasai M; Yamaguchi H; Hosokawa M; Mizushima Y; Kobayashi H
J Natl Cancer Inst; 1981 Aug; 67(2):417-22. PubMed ID: 6267345
[TBL] [Abstract][Full Text] [Related]
19. Conditions favoring immunological enhancement of a murine allogeneic lymphoma.
Rumi L; Colmerauer ME; Pasqualini CD
Arch Geschwulstforsch; 1976; 46(6):457-60. PubMed ID: 63273
[TBL] [Abstract][Full Text] [Related]
20. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system.
Gjedde SB
Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
